Literature DB >> 26656562

Seroprevalence of Toxoplasma gondii infection among patients with non-schizophrenic neurodevelopmental disorders in Alexandria, Egypt.

Amany I Shehata1, Faika I Hassanein2, Rashad Abdul-Ghani3.   

Abstract

Toxoplasma gondii is an opportunistic parasite with neurotropic characteristics that can mediate neurodevelopmental disorders, including mental, behavioral and personality aspects of their hosts. Therefore, the seroprevalence of anti-Toxoplasma antibodies has been studied in patients with different neurological disorders from different localities. On searching online databases, however, we could not find published studies on the seroprevalence of anti-Toxoplasma antibodies among patients with neurodevelopmental disorders in Egypt. Therefore, the present preliminary study was conducted to determine the serological profile of T. gondii infection among patients with non-schizophrenic neurodevelopmental disorders in Alexandria, Egypt. Data and blood samples were collected from 188 patients recruited for the study from four mental rehabilitation centers in the period from July 2014 to March 2015. The overall seropositivity rates of IgM and IgG among patients were 16.5% (31/188) and 50.0% (94/188), respectively. Of the studied patients' characteristics, only age was significantly associated with anti-Toxoplasma IgG seropositivity, with older patients being about twice more likely exposed to infection. However, no statistically significant association was found with IgM. In addition, seropositivity of anti-Toxoplasma IgG, but not IgM, was significantly associated with non-schizophrenic neurodevelopmental disorders; however, neither IgG nor IgM showed a significant association with cognitive impairment as indicated by the intelligence quotient scores.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alexandria; Neurodevelopmental disorder; Seroprevalence; Toxoplasma gondii

Mesh:

Substances:

Year:  2015        PMID: 26656562     DOI: 10.1016/j.actatropica.2015.11.016

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  4 in total

1.  Toxoplasma gondii Seropositivity Interacts with Catechol-O-methyltransferase Val105/158Met Variation Increasing the Risk of Schizophrenia.

Authors:  Paula Rovira; Blanca Gutiérrez; Antonio Sorlózano-Puerto; José Gutiérrez-Fernández; Esther Molina; Margarita Rivera; Rafael Martínez-Leal; Inmaculada Ibanez-Casas; María Victoria Martín-Laguna; Araceli Rosa; Francisco Torres-González; Jorge A Cervilla
Journal:  Genes (Basel)       Date:  2022-06-18       Impact factor: 4.141

2.  Seroprevalence and Genetic Characterization of Toxoplasma gondii among Children with Neurodevelopmental Disorders in Egypt.

Authors:  Sara M Elzeky; Nairmen Nabih; Aida A Abdel-Magied; Dina S Abdelmagid; Aya E Handoussa; Marwa M Hamouda
Journal:  J Trop Med       Date:  2022-05-27

3.  Toxoplasma gondii infection and risk of attention-deficit hyperactivity disorder: a systematic review and meta-analysis.

Authors:  Tooran Nayeri; Shahabeddin Sarvi; Mahmood Moosazadeh; Zahra Hosseininejad; Afsaneh Amouei; Ahmad Daryani
Journal:  Pathog Glob Health       Date:  2020-03-18       Impact factor: 2.894

4.  Aggravation of symptom severity in adult attention-deficit/hyperactivity disorder by latent Toxoplasma gondii infection: a case-control study.

Authors:  Alexandra P Lam; Dominik de Sordi; Helge H O Müller; Martin C Lam; Angelika Carl; Klaus P Kohse; Alexandra Philipsen
Journal:  Sci Rep       Date:  2020-09-01       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.